PT - JOURNAL ARTICLE AU - Nichols, Emma Hitt ED - Eikelboom, John W. TI - Data from New Oral Anticoagulants Provide Clues for Future Drug Development DP - 2013 Sep 01 TA - MD Conference Express PG - 4--5 VI - 13 IP - 13 4099 - http://mdc.sagepub.com/content/13/13/4.short 4100 - http://mdc.sagepub.com/content/13/13/4.full AB - The new oral anticoagulants have delivered promising results in terms of efficacy and safety. However, the data from the many clinical trials that have evaluated the new agents has provided physicians with a wealth of information for future drug development. This article presents five lessons learned from the recent clinical trials that evaluated the novel oral anticoagulant agents, including dabigatran, rivaroxaban, and apixaban.